Focus

Eradicating TB and HIV in the world

Every year, TB and HIV jeopardize the lives of millions of people who lack access to existing treatments due to poverty, conflict, and marginalization.

In 2024, 1.3 million people lost their lives to TB, making it the most common cause of death due to an infectious disease in the world.

Another 9.2 million people with HIV could not access treatment in 2024, endangering their survival and further spreading HIV infection.

TB has been and continues to be the largest cause of death in persons with HIV/AIDS, even though TB is curable, even in people with advanced AIDS.

Drug resistant (DR) TB occurs when the TB bacteria mutates and becomes resistant to antibiotics used to treat ‘regular’ TB. Treatment requires drugs with many side-effects and because of the delays in diagnosis and treatment many patients cycle through ineffective treatments and are left with damaged lungs and weakened hearts even if cured.

Untreated, each patient with DR-TB infects 10 others.

When drug resistant TB infects and causes disease in persons with HIV/AIDS, it is particularly deadly, with mortality increasing 12-fold.

Access to and scale up of TB and HIV care

GHC partners with local staff, communities, and national programs to ensure people have access to treatment for TB, drug resistant TB, and HIV care and to initiate national programs to address these scourges.

We integrate our programs into the local and national health care systems in the countries where we work, so the health infrastructure is strengthened.

We provide each patient with the best care possible while improving standards of local and global care.

We save lives and decrease suffering with the medicines we have in our hands, and use science to find new and better treatments for TB and HIV in the future.